Ligand profile
HQO
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_31481 — Fumarate reductase flavoprotein subunit
Identifiers
Database identifiers and provenance.
- Ligand ID
HQO- PDB
1kf6- UniProt (similar protein)
P00363- Target protein
- KP13_31481
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 47.2
- −1 ≤ LogP ≤ 5 3.69
- MW ≤ 500 Da 259.3
- LogP ≤ 5 3.69
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 47.2
Matches PAINS filter: het_pyridiniums_A(39). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCCCCc1cc(c2ccccc2[n+]1[O-])OCCCCCCCc1cc(c2ccccc2[n+]1[O-])O
InChI=1S/C16H21NO2/c1-2-3-4-5-6-9-13-12-16(18)14-10-7-8-11-15(14)17(13)19/h7-8,10-12,18H,2-6,9H2,1H3InChI=1S/C16H21NO2/c1-2-3-4-5-6-9-13-12-16(18)14-10-7-8-11-15(14)17(13)19/h7-8,10-12,18H,2-6,9H2,1H3
NZPACTGCRWDXCJ-UHFFFAOYSA-NNZPACTGCRWDXCJ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF02300' 'PF02313' 'PF13237
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand HQO →
- PDB RCSB structure 1kf6 →
- UniProt UniProt P00363 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “HQO”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_31481.
PDB 35
Ligands co-crystallized with this protein (structural evidence).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).